BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10964046)

  • 1. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
    Scully C; Field JK; Tanzawa H
    Oral Oncol; 2000 Sep; 36(5):404-13. PubMed ID: 10964046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
    Nylander K; Dabelsteen E; Hall PA
    J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
    Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes.
    Scully C; Bagan JV
    Oral Oncol; 2008 Mar; 44(3):211-5. PubMed ID: 18261952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in oral, head, and neck cancer.
    McGuff HS; Aufdemorte TB
    Tex Dent J; 1998 Jun; 115(6):31-5. PubMed ID: 9667210
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of head and neck cancer.
    Gleich LL; Salamone FN
    Cancer Control; 2002; 9(5):369-78. PubMed ID: 12410176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
    Szczepanski MJ; Whiteside TL
    Biomark Med; 2013 Aug; 7(4):575-8. PubMed ID: 23905893
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathogenesis of head and neck squamous cell carcinoma.
    Hardisson D
    Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic screening of head and neck cancer and its implications for therapy planning.
    Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):295-6. PubMed ID: 16575585
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
    Emich H; Chapireau D; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essentials of oral cancer.
    Rivera C
    Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FORĀ ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.
    Krishnan M; Babu S; Jayaraman S; Daniel P; Solomon A; Chinnaiyan M
    Exp Oncol; 2022 Nov; 44(3):263-264. PubMed ID: 36325699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current concepts in diagnosis and treatment of oral malignant tumors].
    Hullmann MM; Reichert TE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Sep; 54(9):1083-8. PubMed ID: 21887623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance.
    Smith BD; Haffty BG; Sasaki CT
    Ann Otol Rhinol Laryngol; 2001 Mar; 110(3):221-8. PubMed ID: 11269765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.